Becker's Healthcare September 24, 2025
A $3.5 million philanthropic gift is helping Cleveland-based University Hospitals Seidman Cancer Center triple its clinical trial capacity by 2030 — part of a broader push to expand cancer research and innovation while decentralizing early-phase trial access across its 23-hospital system.
Leading the charge are Theodoros Teknos, MD, president and scientific director of the UH Seidman Cancer Center and the Jane and Lee Seidman Chair in Cancer Innovation, and Quintin Pan, PhD, deputy director for research of the UH Seidman Cancer Center and the Dr. Lester E. Coleman, Jr. Chair in Cancer Research & Therapeutics.
They spoke to Becker’s about their clinical trial expansion strategy, how AI will enable streamlined trial enrollment and their mindset amid federal funding uncertainty.
...Today's Sponsors
Today's Sponsor